These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19247814)

  • 1. Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer.
    Ren T; Jiang B; Xing X; Dong B; Peng L; Meng L; Xu H; Shou C
    Pathol Oncol Res; 2009 Dec; 15(4):555-60. PubMed ID: 19247814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome.
    Wang L; Peng L; Dong B; Kong L; Meng L; Yan L; Xie Y; Shou C
    Ann Oncol; 2006 Oct; 17(10):1517-22. PubMed ID: 16873432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma.
    Reich R; Hadar S; Davidson B
    Int J Mol Sci; 2011 Feb; 12(2):1133-45. PubMed ID: 21541048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer.
    Liu C; Zhong W; Xia L; Fang C; Liu H; Liu X
    Medicine (Baltimore); 2021 Apr; 100(17):e25658. PubMed ID: 33907129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.
    Liu H; Al-aidaroos AQ; Wang H; Guo K; Li J; Zhang HF; Zeng Q
    BMC Cancer; 2013 Feb; 13():80. PubMed ID: 23418787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.
    Bilici A; Ustaalioglu BB; Yavuzer D; Seker M; Mayadagli A; Gumus M
    Dig Dis Sci; 2012 Jun; 57(6):1568-75. PubMed ID: 22331511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal and Phosphatase of Regenerating Liver-3 Status in Circulating Tumor Cells May Serve as a Crucial Prognostic Marker for Assessing Relapse or Metastasis in Postoperative Patients With Colorectal Cancer.
    Su P; Lai W; Liu L; Zeng Y; Xu H; Lan Q; Chu Z; Chu Z
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00265. PubMed ID: 33512811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer.
    Hao RT; Zhang XH; Pan YF; Liu HG; Xiang YQ; Wan L; Wu XL
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1349-57. PubMed ID: 20140626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer.
    Ustaalioglu BB; Bilici A; Barisik NO; Aliustaoglu M; Vardar FA; Yilmaz BE; Seker M; Gumus M
    Clin Transl Oncol; 2012 Dec; 14(12):911-22. PubMed ID: 22855168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
    Xu Y; Zhu M; Zhang S; Liu H; Li T; Qin C
    Pathol Oncol Res; 2010 Jun; 16(2):169-75. PubMed ID: 19757198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer.
    Dai N; Lu AP; Shou CC; Li JY
    World J Gastroenterol; 2009 Mar; 15(12):1499-505. PubMed ID: 19322925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
    Zhou J; Wang S; Lu J; Li J; Ding Y
    Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined expression of metastasis related markers Naa10p, SNCG and PRL-3 and its prognostic value in breast cancer patients.
    Min L; Ma RL; Yuan H; Liu CY; Dong B; Zhang C; Zeng Y; Wang L; Guo JP; Qu LK; Shou CC
    Asian Pac J Cancer Prev; 2015; 16(7):2819-26. PubMed ID: 25854368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of PRL-3 overexpression in early stages of colonic cancer.
    Xing X; Peng L; Qu L; Ren T; Dong B; Su X; Shou C
    Histopathology; 2009 Feb; 54(3):309-18. PubMed ID: 19236507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma.
    Xing X; Lian S; Hu Y; Li Z; Zhang L; Wen X; Du H; Jia Y; Zheng Z; Meng L; Shou C; Ji J
    J Transl Med; 2013 Dec; 11():309. PubMed ID: 24330843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
    Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.
    Xu Y; Wang C; Zhang Y; Jia L; Huang J
    Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.
    Mu N; Gu J; Liu N; Xue X; Shu Z; Zhang K; Huang T; Chu C; Zhang W; Gong L; Zhao H; Jia B; Gao D; Shang L; Zhang W; Guo Q
    Theranostics; 2018; 8(6):1527-1539. PubMed ID: 29556339
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer.
    Andersen S; Richardsen E; Rakaee M; Bertilsson H; Bremnes R; Børset M; Busund LT; Slørdahl T
    PLoS One; 2017; 12(11):e0189000. PubMed ID: 29190795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of phosphatase of regenerating liver-3 (PRL-3) in endometrioid cancer and lymph nodes metastases.
    Guzińska-Ustymowicz K; Kiśluk J; Terlikowski SJ; Pryczynicz A; Niewiarowska K; Ustymowicz M; Hawryluk M; Południewski M; Kemona A
    Adv Med Sci; 2013; 58(2):221-6. PubMed ID: 23729584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.